HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice

por Stöver, H., Dichtl, A., Schäffer, D., Grabski, M.
Publicado 2023

Relapses in Illicit Drug Use Among Probationers: Results in a Risk Group of Public Health Services in Bavaria

por Kappl, U., Sakr, A. M., Huppertz, B., Stöver, H., Stich, H.
Publicado 2023

Overview of availability of harm reduction interventions in European prisons

por Montanari, L, Mazzilli, S, Tarján, A, Hasselberg, I, Hall, W, Vandam, L, Vernooij, A, Stöver, H
Publicado 2022

COVID-19 vaccination in prison settings: a model to design tailored vaccine delivery strategies: Lara Tavoschi

por Tavoschi, L, Mazzilli, S, Petri, D, Busmachiu, V, Stylianou, I, Meroueh, F, Stöver, H, Rosello, A, Ranieri, R, Baglietto, L
Publicado 2022

Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe

por Stöver, H., Meroueh, F., Marco, A., Keppler, K., Saiz de la Hoya, P., Littlewood, R., Wright, N., Nava, F., Alam, F., Walcher, S., Somaini, L.
Publicado 2019